From our Annual Public Meeting to topic-specific convenings, the Reagan-Udall Foundation for the FDA brings stakeholders together on matters critical to regulatory science and practice. These events, often hosted at the request of FDA leadership, provide space for expert analysis and candid discussion on FDA’s priority issues. See below for upcoming events.

Past Events

In the article, Wasser explains why the FDA asked its foundation to create a public-pri
Executive Director June Wasser
The Post and other publications picked up CQ-Roll Call's Andrew Siddons' analysis of the potential impact of federal Right-To-Try legislation.
In this article, Interim President and CEO Ellen Willmot shares her hope that the Navigator will make it easier for breast cancer physicians and patients to apply for, and benefit from, expanded access to investigational t
The American Society of Clinical Oncology helped develop the Navigator and in this post describes it as a clearinghouse for the single-patient exp
This post points out that the Navigator will expand from an oncology focus to other thera
This magazine article says the Navigator streamlines information-gathering and links the lau
This blog from the Biotechnology Innovation Organization reminds companies they can comply with the 21st Centu